IFNGR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62492241884138E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.11022302462516E-16 |
Normal-vs-Stage2 |
4.67339999998817E-06 |
Normal-vs-Stage3 |
4.28430002585856E-09 |
Normal-vs-Stage4 |
5.55779999800166E-08 |
Stage1-vs-Stage2 |
4.044400E-01 |
Stage1-vs-Stage3 |
4.584600E-01 |
Stage1-vs-Stage4 |
3.558600E-01 |
Stage2-vs-Stage3 |
8.889600E-01 |
Stage2-vs-Stage4 |
9.756600E-01 |
Stage3-vs-Stage4 |
8.995000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.33066907387547E-16 |
Normal-vs-AfricanAmerican |
1.87442999999288E-05 |
Normal-vs-Asian |
4.414300E-04 |
Caucasian-vs-AfricanAmerican |
2.570400E-01 |
Caucasian-vs-Asian |
8.127800E-01 |
AfricanAmerican-vs-Asian |
4.920800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
5.6390447866761E-12 |
Male-vs-Female |
6.667900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.606230E-02 |
Normal-vs-Age(41-60Yrs) |
1.62980740014973E-12 |
Normal-vs-Age(61-80Yrs) |
1.66888725061654E-12 |
Normal-vs-Age(81-100Yrs) |
4.160900E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.061800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.935600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.230200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.515800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.729800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.262600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.30139999782375E-08 |
Normal-vs-Grade 2 |
1.11022302462516E-16 |
Normal-vs-Grade 3 |
2.63833399571922E-12 |
Normal-vs-Grade 4 |
4.8467000000052E-06 |
Grade 1-vs-Grade 2 |
4.155800E-01 |
Grade 1-vs-Grade 3 |
4.060400E-02 |
Grade 1-vs-Grade 4 |
8.391800E-02 |
Grade 2-vs-Grade 3 |
2.043800E-02 |
Grade 2-vs-Grade 4 |
5.377600E-02 |
Grade 3-vs-Grade 4 |
6.220200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62447832963153E-12 |
Normal-vs-ccB subtype |
5.49239986824546E-10 |
ccA subtype-vs-ccB subtype |
3.885600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63646873829748E-12 |
Normal-vs-N1 |
5.466400E-02 |
N0-vs-N1 |
9.006200E-01 |
|
|